Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121814) titled 'Study on Brain Mechanisms of Magnetic Seizure Therapy for Treatment-Resistant Schizophrenia' on April 3.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Shanghai Mental Health Center
Condition:
Treatment-Resistant Schizophrenia
Intervention:
antipsychotic drug group:None
magnetic seizure therapy group:magnetic seizure therapy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-15
Target Sample Size: antipsychotic drug group:35;magnetic seizure therapy group:35;healthy control group:35;
Countries of Recruitment:
China
To know more...